Význam brain-derived neurotrophic factor (BDNF) genetického polymorfismu a hladin BDNF pro predikci, diagnostiku a monitoraci kognitivního deficitu u neurodegenerativních onemocnění

Alzheimer's disease (AD) is a slowly progressing neurodegenerative disease characterized by an extracellular accumulation of senile plaques and intracellular neurofibrillary tangles. Apart from these hallmarks, AD is very heterogeneous, especially at the age of onset and the rate of progression...

Full description

Bibliographic Details
Main Author: Čechová, Kateřina
Other Authors: Hort, Jakub
Format: Doctoral Thesis
Language:Czech
Published: 2021
Online Access:http://www.nusl.cz/ntk/nusl-439895
id ndltd-nusl.cz-oai-invenio.nusl.cz-439895
record_format oai_dc
spelling ndltd-nusl.cz-oai-invenio.nusl.cz-4398952021-05-31T05:11:07Z Význam brain-derived neurotrophic factor (BDNF) genetického polymorfismu a hladin BDNF pro predikci, diagnostiku a monitoraci kognitivního deficitu u neurodegenerativních onemocnění The impact of brain-derived neurotrophic factor (BDNF) gene polymorphism and BDNF levels for prediction, diagnosis and follow-up of cognitive deficit in neurodegenerative diseases Čechová, Kateřina Hort, Jakub Telenský, Petr Rektorová, Irena Alzheimer's disease (AD) is a slowly progressing neurodegenerative disease characterized by an extracellular accumulation of senile plaques and intracellular neurofibrillary tangles. Apart from these hallmarks, AD is very heterogeneous, especially at the age of onset and the rate of progression. Genetic polymorphisms are key modulators influencing these factors. One of them is a polymorphism for the Brain-derived neurotrophic factor (BDNF), a neurotrophin involved in the synaptic plasticity in the hippocampus and medial temporal lobe structures, areas primarily affected in AD. The thesis aimed to investigate the effect of BDNF Va66Met polymorphism together with the main genetic risk factor for sporadic AD, Apolipoprotein E (APOE) polymorphism, on cognitive functions and structural brain changes. We have shown that the combination of risk alleles BDNF Met and APOE ɛ4 is associated with more severe impairment in episodic memory, egocentric orientation and smaller volumes of medial temporal lobe structures in individuals with amnestic mild cognitive impairment (aMCI), and allocentric orientation in cognitively unimpaired individuals compared to non-carriers. These findings suggest that carriers of the combination of BDNF Met and APOE ɛ4 have a higher risk of progression to more severe disease stages,... 2021 info:eu-repo/semantics/doctoralThesis http://www.nusl.cz/ntk/nusl-439895 cze info:eu-repo/semantics/restrictedAccess
collection NDLTD
language Czech
format Doctoral Thesis
sources NDLTD
description Alzheimer's disease (AD) is a slowly progressing neurodegenerative disease characterized by an extracellular accumulation of senile plaques and intracellular neurofibrillary tangles. Apart from these hallmarks, AD is very heterogeneous, especially at the age of onset and the rate of progression. Genetic polymorphisms are key modulators influencing these factors. One of them is a polymorphism for the Brain-derived neurotrophic factor (BDNF), a neurotrophin involved in the synaptic plasticity in the hippocampus and medial temporal lobe structures, areas primarily affected in AD. The thesis aimed to investigate the effect of BDNF Va66Met polymorphism together with the main genetic risk factor for sporadic AD, Apolipoprotein E (APOE) polymorphism, on cognitive functions and structural brain changes. We have shown that the combination of risk alleles BDNF Met and APOE ɛ4 is associated with more severe impairment in episodic memory, egocentric orientation and smaller volumes of medial temporal lobe structures in individuals with amnestic mild cognitive impairment (aMCI), and allocentric orientation in cognitively unimpaired individuals compared to non-carriers. These findings suggest that carriers of the combination of BDNF Met and APOE ɛ4 have a higher risk of progression to more severe disease stages,...
author2 Hort, Jakub
author_facet Hort, Jakub
Čechová, Kateřina
author Čechová, Kateřina
spellingShingle Čechová, Kateřina
Význam brain-derived neurotrophic factor (BDNF) genetického polymorfismu a hladin BDNF pro predikci, diagnostiku a monitoraci kognitivního deficitu u neurodegenerativních onemocnění
author_sort Čechová, Kateřina
title Význam brain-derived neurotrophic factor (BDNF) genetického polymorfismu a hladin BDNF pro predikci, diagnostiku a monitoraci kognitivního deficitu u neurodegenerativních onemocnění
title_short Význam brain-derived neurotrophic factor (BDNF) genetického polymorfismu a hladin BDNF pro predikci, diagnostiku a monitoraci kognitivního deficitu u neurodegenerativních onemocnění
title_full Význam brain-derived neurotrophic factor (BDNF) genetického polymorfismu a hladin BDNF pro predikci, diagnostiku a monitoraci kognitivního deficitu u neurodegenerativních onemocnění
title_fullStr Význam brain-derived neurotrophic factor (BDNF) genetického polymorfismu a hladin BDNF pro predikci, diagnostiku a monitoraci kognitivního deficitu u neurodegenerativních onemocnění
title_full_unstemmed Význam brain-derived neurotrophic factor (BDNF) genetického polymorfismu a hladin BDNF pro predikci, diagnostiku a monitoraci kognitivního deficitu u neurodegenerativních onemocnění
title_sort význam brain-derived neurotrophic factor (bdnf) genetického polymorfismu a hladin bdnf pro predikci, diagnostiku a monitoraci kognitivního deficitu u neurodegenerativních onemocnění
publishDate 2021
url http://www.nusl.cz/ntk/nusl-439895
work_keys_str_mv AT cechovakaterina vyznambrainderivedneurotrophicfactorbdnfgenetickehopolymorfismuahladinbdnfpropredikcidiagnostikuamonitoracikognitivnihodeficituuneurodegenerativnichonemocneni
AT cechovakaterina theimpactofbrainderivedneurotrophicfactorbdnfgenepolymorphismandbdnflevelsforpredictiondiagnosisandfollowupofcognitivedeficitinneurodegenerativediseases
_version_ 1719408224954744832